Top Tweets for #CVdeath
#VICTOR #ESCCongress #LBCT
🫀Vericiguat in Chronic #HFrEF
🫀population:1/2 no prior HF hospitalization, excellent GDMT
🫀 Nonetheless, no significant finding of difference of Vericiguat 🆚 Placebo
🫀did ⤵️ risk of CV death
#VICTOR & #VICTORIA pooled analysis by Prof @JavedButler1 at #ESCCongress #LBCT
📍 >11,000 pts with chronic #HFrEF
📍#Vericiguat ⬇️ risk of all-cause death, #CVdeath & #HHF across broad spectrum of disease
📍Benefit most notable in pts with NT-proBNP ≤6000 pg/mL
📍Well tolerated, favorable safety profile
@escardio #HeartFailure #GDMtTworks
#VICTOR results from #ESCCongress #LBCT presented by @FaiezZANNAD
📍#Vericiguat did NOT ⬇️ #CVdeath or #HHF in ambulatory #HFrEF on #GDMT
📍Secondary analysis: significant ⬇️ #CVdeath
📍Favorable effects in compensated #HFrEF outpatients
@escardio @JavedButler1
🔥DAPA ACT HF-TIMI 68 trial results
Fresh from #ESCCongress
📍No significant ⬇️ in #CVdeath or worsening HF at 2 months with in-hospital #Dapagliflozin
⚠️But‼️
📍 Meta-analysis with other RCTs: early in-hospital #SGLT2i initiation ⬇️ adverse outcomes including #CVdeath & all-cause mortality post-discharge
📍Safe & well-tolerated, consistent with SGLT2i class profile
@escardio @ddbergMD @TIMIStudyGroup @CVR_TomaszGuzik @jozinetm #GDMTworks
Elevated IL-6 & hs-CRP levels = higher risk of worsening HF or #cvDeath in #HFrEF patients, based on DAPA-HF study.
✅ However, #dapagliflozin reduced outcomes regardless of baseline inflammation
📎https://t.co/AAQtJovnUi
#JACCHF #HeartFailure @scottdsolomon
"Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath"
#EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath
Read our recently published evidence-based statement, which reinforces our ongoing commitment to science-driven public health, at a time when misinformation is putting lives at risk https://t.co/l6Fy1pFVVw
Link to the press release: https://t.co/VVT1L0Mivj
#HFA_ESC #EAPC_ESC #ACVC_ESC #COVID19 #infection #influenza #pneumococcus
#EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath
Read our recently published evidence-based statement, which reinforces our ongoing commitment to science-driven public health, at a time when misinformation is putting lives at risk https://t.co/l6Fy1pFVVw
Link to the press release: https://t.co/VVT1L0Mivj
#HFA_ESC #EAPC_ESC #ACVC_ESC #COVID19 #infection #influenza #pneumococcus
📌 Do you know that #cannabis use
🔊 assoc. w/ ⬆️ risk of
🔹🧠 #Stroke 👉 RR=1.20
🔹❤️🔥 #AcuteCoronarySyndrome 👉 RR=1.29
🔹☠️ #CVdeath 👉 RR=2.10 ❗️
#CardioTwitter #MedTwitter #medstudent #Review @DrMarthaGulati @AnastasiaSMihai @cpgale3 @mmamas1973 @SeguraCardio @Hragy @iamritu
HELIOS-B: #Vutrisiran reduces all-cause mortality, presented by @MariannaFonta11
📍 Significant reduction in all-cause & #CVdeath ☠️ over 42 months vs placebo
📍 Lower rates of #CVevents and #HF hospitalisations 🏥 over 36 months vs placebo
#ATTR #cardiacamyloidosis
#HeartFailure2025 #HFA_ESC
@escardio
#FINE_HEART: #Finerenone in #CKD and #T2DM
Pooled analysis from #FINEARTS_HF, #FIDELIO_DKD #FIGARO_DKD
📍18.991 pts, median 2.9 years
📍#CVdeath: ⬇️ 11%
📍All-cause death: ⬇️ 9%
📍#HeartFailure Hospitalizations: ⬇️17%
📍#Kidney ⬆️ 20%
#ESCCongress
#FINEARTS_HF LIVE from #ESCCongress:
📍The first-ever trial of #MRA in #HFpEF / #HFmrEF to hit its primary endpoint! 🎯
#Finerenone:
📍16% reduction in the primary endpoint 🔥
📍Absolute risk reduction of 3.3/100 patient-years for #CVdeath and total #WHF 💪
📍Improved symptoms, safe, and well tolerated🌟
#Cardiology #HeartFailure #FunctionNotFailure
@scottdsolomon @WilfriedMullens
🚨‼️#ESCCongress 2024 🇬🇧
HOTLINE: #FINEARTSHF study just released by Scott Solomon 😵
👉🏼Finerenone versus placebo among patients with HFmrEF and HFpEF
🎯FINEARTS-HF met its primary endpoint: ⬇️ 16% CV death and total HF events
🏅Another game changer for HFpEF!!
@escardio
🔴 Contemporary Use & Implications of Beta-Blockers in Ptsw/ HFmrEF or HFpEF: The DELIVER Trial
✅BB use wasn't linked to #worseningHF or #cvDeath. Benefits of #dapa remained regardless of BBs, reassuring their role in Rx HFpEF/ HFmrEF alongside #SGLT2i. https://t.co/LX768Ji1gc
#BetaBlocker use in #HFpEF and #HFmrEF❓
In this month’s issue of #JACCHF, analysis of #DELIVER trial shows:
♥️ 4 out of 5 px were treated with #BB
♥️#BB use wasn't linked to #worseningHF or #CVdeath
♥️Benefits of #Dapagliflozin remained consistent regardless of #BB
➡️➡️ reassuring for background #BB use in #HFpEF / #HFmrEF alongside #SGLT2i
🔗: https://t.co/lANbPOtjE0
Analysis of #DELIVER trial shows that beta-blocker use wasn't linked to #worseningHF or #cvDeath. Benefits of #dapagliflozin remained consistent regardless of beta-blockers, reassuring their role in treating #HFpEF or #HFmrEF alongside #SGLT2i. https://t.co/PmHo26MDOq #JACCHF
Moderate/severe TR raises #HeartFailure & #CVdeath risk in #HFrEF patients, highlighting the need for TR management. This study also shows that omecamtiv mecarbil’s effectiveness remains unaffected by TR severity. https://t.co/CTw0YXNAxV
#JACCHF @MariannaAdamo1 @MarcoMetra
Relationship between #TricuspidRegurgitation x #HFrEF❓
🫀Moderate/severe TR ⬆️ risk of HF events& #CVdeath, highlighting the importance of managing TR in HF‼️
🫀Omecamtiv mecarbil was effective regardless of TR severity
More 🖇️: https://t.co/qTIbkT1jt3 #JACCHF #GALACTICHF
Sotagliflozin reduces relative risk of hospital readmissions for #HeartFailure by 53% & composite of #CVdeath or #HF readmission by 52% within 30 days of discharge. https://t.co/W7xcmWB0yL
#JACCHF #SOLOISTWHF #SGLT2i #Sotagliflozin #CardioTwitter #GDMT #cardioEd #Cardiology
#FINALITY-HF will evaluate #FINERENONE vs #PLACEBO in 2,600 #HFrEF patients not on #sMRA on #CVDeath and #HF Events. #MOONRAKER @MkosiborodMD @BayerPharma @MarcBonaca @cpcannon @AndrewJSauer @anita_deswal @EriKato71362632 @MicheleSenni @HeerspinkHiddo https://t.co/QE27uFTNDr
#REDEFINE-HF (NCT06008197) will assess #FINERENONE vs #PLACEBO in 5,200 acute #HFmrEF or #HFpEF patients on #CVDeath & #HF Events. #MOONRAKER @MkosiborodMD @BayerPharma @MarcBonaca @cpcannon @AndrewJSauer @JavedButler1 @lamcardio @scottdsolomon @KSharmaMD https://t.co/QE27uFUlsZ
Last Seen Hashtags on Sotwe
selenaloca
ometv
Seen from Germany
Happytails
Seen from United States
ipcam((((((((******))))))))filter:videos
Seen from Spain
SUPERJUNIOR_PAUSE
Seen from United States
HoustonHotties
Seen from United States
山奥の廃寺
Seen from United States
esinÇepni
Seen from Germany
izmirtraveſtileri
Seen from Germany
helenaprestes
Seen from Italy
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.2M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.2M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers